BioCryst Pharmaceuticals, Inc. has released new real-world evidence demonstrating significant and sustained reductions in Hereditary Angioedema (HAE) attack rates in adolescents and individuals with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback